Richard Colbeck (Tasmania, Liberal Party, Minister for Aged Care and Senior Australians) Share this | Hansard source

As part of our announcement yesterday, the Minister for Health made a number of announcements with respect to the prescription of psychotropics—risperidone being the key one—and also antipsychotics. From 1 January, off the back of recommendations of the Pharmaceutical Benefits Advisory Committee, prescriptions for risperidone will be restricted and doctors will be required to apply for additional approvals if risperidone is to be prescribed beyond the initial 12 weeks. We've also put an additional $10 million into dementia management and training capacity. That adds to the $37 million that's been spent this year for those programs. So, from $37 million this year, it will go to $45 million in 2019-20.